Royal Bank of Canada’s Teladoc Health TDOC Stock Holding History

Royal Bank of Canada’s Portfolio TDOC Stock Details TDOC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,500	Closed	-$63K	–	7580
2023 Q2	$63K	Buy	+2,500	New	+$62.9K	﹤0.01%	5656
2022 Q4	–	Sell	-15,000	Closed	-$380K	–	7708
2022 Q3	$380K	Sell	15,000 -25,000	-63%	-$877K	﹤0.01%	4252
2022 Q2	$1.33M	Hold	40,000	–	–	﹤0.01%	3243
2022 Q1	$2.88M	Hold	40,000	–	–	﹤0.01%	2728
2021 Q4	$3.67M	Buy	40,000 +15,000	+60%	+$1.79M	﹤0.01%	2614
2021 Q3	$3.17M	Hold	25,000	–	–	﹤0.01%	2686
2021 Q2	$4.16M	Buy	+25,000	New	+$4.05M	﹤0.01%	2443
2021 Q1	–	Sell	-7,800	Closed	-$1.56M	–	7689
2020 Q4	$1.56M	Sell	7,800 -300	-4%	-$61K	﹤0.01%	3147
2020 Q3	$1.78M	Sell	8,100 -800	-9%	-$169K	﹤0.01%	2783
2020 Q2	$1.7M	Buy	+8,900	New	+$1.56M	﹤0.01%	2756
2018 Q1	–	Sell	-21,800	Closed	-$760K	–	6775
2017 Q4	$760K	Buy	+21,800	New	+$724K	﹤0.01%	3449

Other funds holding TDOC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Royal Bank of Canada's TDOC Position: Q1 2026 in Review

Royal Bank of Canada reduced its Teladoc Health (TDOC) stake by 17% in Q1 2026, selling an estimated $99.6K and leaving 85,453 shares worth $465K. The position accounts for ﹤0.01% of the portfolio, ranked #4201.

Royal Bank of Canada first reported a position in TDOC in Q3 2015 and has held it in 43 quarters since. The position peaked at $137M in Q4 2020. 323 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

Royal Bank of Canada held 85,453 shares of Teladoc Health worth $465K as of Q1 2026.
Royal Bank of Canada sold 17,755 Teladoc Health shares in Q1 2026, an estimated $99.6K.
Teladoc Health made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #4201 holding.
Royal Bank of Canada first reported a position in Teladoc Health in Q3 2015 and has held it in 43 quarters since.
Royal Bank of Canada's Teladoc Health position peaked at $137M in Q4 2020.
323 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.